Holen Sie sich die Stockscreener-App
9.23
0.65%
-0.06
Handel nachbörslich:
9.74
0.51
+5.53%
Schlusskurs vom Vortag:
$9.29
Offen:
$9.25
24-Stunden-Volumen:
820.61K
Relative Volume:
1.49
Marktkapitalisierung:
$977.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-174.61M
KGV:
-4.3744
EPS:
-2.11
Netto-Cashflow:
$-165.54M
1W Leistung:
+12.84%
1M Leistung:
+28.37%
6M Leistung:
+0.11%
1J Leistung:
+9.75%
1-Tages-Spanne:
$8.98
$9.49
1-Wochen-Bereich:
$7.67
$9.52
52-Wochen-Spanne:
$6.8802
$16.63
89 Bio Inc Stock (ETNB) Company Profile
Firmenname
89 Bio Inc
Sektor
Branche
Telefon
(415) 432-9270
Adresse
142 SANSOME STREET, SAN FRANCISCO, CA
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-12 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-26 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Eingeleitet | Raymond James | Strong Buy |
| 2020-09-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-23 | Eingeleitet | BTIG Research | Buy |
| 2020-07-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-12-09 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-12-09 | Eingeleitet | Oppenheimer | Outperform |
| 2019-12-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-12-09 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
89 Bio Inc Aktie (ETNB) Neueste Nachrichten
89bio to Participate in the UBS Global Healthcare Conference - The Manila Times
89bio (NASDAQ:ETNB) Shares Gap DownShould You Sell? - MarketBeat
Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH - Yahoo Finance
89bio's chief technical operations officer sells $226,994 in stock - Investing.com India
89bio's chief technical operations officer sells $226,994 in stock By Investing.com - Investing.com Australia
89bio (NASDAQ:ETNB) Trading 7.3% HigherStill a Buy? - MarketBeat
89Bio: Surviving A Competitive SpaceFor Now (NASDAQ:ETNB) - Seeking Alpha
Global Severe Hypertriglyceridemia (SHTG) Treatment Market Set to Reach USD 2675.37 Million by 2033 - PharmiWeb.com
Canadian North Resources Inc. Reports Metal Extraction of 96-98% Nickel and Cobalt Using Low-carbon Footprint - EIN News
Canadian North Resources Inc. Reports Metal Extraction of 96-98% Nickel and Cobalt Using Low-carbon Footprint Bio-Leaching Technology for the Ferguson Lake Project - The Manila Times
Canadian North Resources Inc. Reports Metal Extraction of - GlobeNewswire
Oak Valley Bancorp reports Q3 EPS 89c vs. 89c last year - Yahoo Finance
Deckers Stock Rallies 89% in a Year: Lock in Gains or Stay Invested? - Yahoo Finance
89bio, Inc. (NASDAQ:ETNB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Suvretta Capital Management's Strategic Reduction in 89bio Inc Holdings - Yahoo Finance
89bio, Inc. (NASDAQ:ETNB) Short Interest Update - MarketBeat
State Street Corp's Strategic Acquisition in 89bio Inc - Yahoo Finance
89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024 - The Manila Times
89bio Inc (ETNB) presents a great opportunity, but the stock is slightly overvalued - US Post News
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
PCR Technologies Market to Hit USD 21.89 Billion by 2030 with 7.7% CAGR | MarketsandMarkets™ - PR Newswire
Millennium Management LLC Sells 76,845 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio (NASDAQ:ETNB) Trading Up 5.3%Here's Why - MarketBeat
89bio Inc [ETNB] Chief Executive Officer makes an insider purchase of 52,718 shares worth 0.58 million. - Knox Daily
Renaissance Technologies LLC Invests $2.24 Million in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
Bank of Montreal Can Has $4.64 Million Stake in Repligen Co. (NASDAQ:RGEN) - Defense World
89bio Inc (ETNB)’s stock price range in the last year - US Post News
89bio to Participate in the H.C. Wainwright 8th Annual MASH Investor Conference - ForexTV.com
The Potential Rise in the Price of 89bio Inc (ETNB) following insiders activity - Knox Daily
What is 89bio Inc (ETNB) Stock Return on Shareholders’ Capital? - SETE News
Metric Deep Dive: Understanding 89bio Inc (ETNB) Through its Ratios - The Dwinnex
Severe Hypertriglyceridemia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, 89bio, Inc., Arrowhead Pharma, Hightide Therapeutics, AstraZeneca, Kowa - Barchart
Severe Hypertriglyceridemia Market Growth to Accelerate - openPR
89Bio's SWOT analysis: pegoza's potential in competitive MASH market - Investing.com
89Bio's SWOT analysis: pegoza's potential in competitive MASH market By Investing.com - Investing.com Australia
Health Check: How Prudently Does 89bio (NASDAQ:ETNB) Use Debt? - Simply Wall St
89bio Inc (ETNB) did well last session? - US Post News
In the Green: 89bio Inc (ETNB) Closes at 7.67, Up/Down -6.35 from Previous Day - The Dwinnex
89bio (NASDAQ:ETNB) Trading Down 2.9% - MarketBeat
89bio, Inc. (NASDAQ:ETNB) Receives $30.14 Average PT from Brokerages - MarketBeat
Adversity is less terrifying than hope: 89bio Inc (ETNB) - SETE News
Integral Health Asset Management LLC Buys 150,000 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio's (ETNB) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat
Balakrishna pays tribute to ANR on his 100th Birth Anniversary - TrackTollywood
2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders - Fierce Biotech
Saba capital management sells shares in Eaton Vance trust worth over $484k - Investing.com
Brokerages Set East West Bancorp, Inc. (NASDAQ:EWBC) Price Target at $89.53 - Defense World
Ratio Examination: 89bio Inc (ETNB)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Teresa Perney brought in to lead 89bio’s regulatory strategy - The Pharma Letter
Bank of New York Mellon Corp Has $2.40 Million Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Peter Maag resigns as Kyverna CEO - BioCentury
Finanzdaten der 89 Bio Inc-Aktie (ETNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):